Cresco Labs Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

0.6499$ +2.2% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Cresco Labs Inc. (CRLBF) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,263 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CRLBF
Line item	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	74	149	318	364	355	417	617	1,157	1,209	1,207	1,333	1,407	1,595	1,570	1,780	–	1,701	1,756	1,584	1,551	1,511	1,399	1,358	1,360	1,358	1,383	1,355	1,364	1,348	1,280	1,197	1,199	1,263
Current Assets	–	46	113	193	183	160	190	159	216	257	257	362	382	294	449	422	400	314	355	327	286	265	303	278	285	273	312	294	311	315	243	259	247	246
Cash	–	32	94	131	106	61	74	49	69	71	58	136	256	131	253	224	–	90	130	119	90	73	107	103	123	112	153	138	155	147	45	58	32	33
Receivables	–	2.3	2.9	11	5.3	8.3	14	17	17	19	30	32	39	45	50	45	49	45	52	56	50	58	57	51	50	54	55	52	45	39	43	38	38	40
Inventory	–	6.0	7.7	25	36	66	75	50	81	100	108	137	75	103	132	137	156	159	153	135	135	121	115	108	98	95	92	83	87	89	93	99	108	111
Property, Plant & Equipment	–	17	24	40	95	107	129	202	263	269	266	284	313	374	420	453	481	487	502	380	512	388	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	51	51	51	51	138	458	452	452	452	460	564	396	447	–	448	448	331	331	310	280	280	280	283	284	283	283	283	283	208	209	222
Intangible Assets	–	3.4	3.6	25	25	25	27	94	193	200	196	196	215	335	269	438	–	433	431	408	406	403	298	297	298	300	296	294	293	289	292	275	288	321
Total Liabilities	–	7.3	9.3	35	87	83	101	294	417	472	465	608	697	665	858	983	–	917	985	996	983	964	973	930	940	984	1,018	967	989	987	940	945	955	1,000
Current Liabilities	–	5.4	7.3	25	37	32	46	150	141	163	244	195	277	195	209	288	331	228	271	281	273	238	261	200	209	137	159	94	113	101	97	100	98	138
Short-Term Debt	–	0.2	–	–	0.3	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Accounts Payable	–	2.8	5.0	4.4	7.4	11	12	32	35	38	29	26	37	22	26	32	33	37	29	28	20	20	20	28	17	19	19	14	18	17	17	17	14	16
Long-Term Debt	–	–	–	–	44	–	–	–	96	96	7.4	169	258	264	464	465	–	467	468	469	471	472	491	498	498	499	499	461	371	372	327	417	418	420
Shareholders' Equity	22	49	139	121	118	116	162	187	610	595	612	574	612	883	670	756	–	800	789	627	607	623	506	506	503	468	457	475	462	444	428	340	336	359
Retained Earnings	–	-14	-11	-53	-60	-66	-86	-115	-130	-155	-204	-286	-443	-535	-813	-842	-880	-900	-915	-1,076	-1,106	-1,154	-1,271	-1,266	-1,274	-1,336	-1,346	-1,352	-1,369	-1,390	-1,409	-1,500	-1,516	-1,499
Shares Outstanding	–	–	–	–	–	–	–	132	201	207	217	223	243	246	274	274	–	299	301	301	309	309	338	340	342	348	348	349	353	355	357	360	370	372

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings